HTGM
HTG Molecular Diagnostics Inc
-37.26%
$4.67 - $2.93
Feb 7th 2023 - Mar 21st 2023
Jan, 23, 2023
Micro float (~600K), great company with increase i... See more
Jan, 20, 2023
$HTGM primed for $10+: STRONG BUY signal 700K flo... See more
GNUS
Genius Brands International Inc
-61.31%
$6.54 - $2.53
Feb 8th 2023 - Mar 22nd 2023
Jan, 20, 2023
GNUS GNUS ⚠️ 📢 🚨 ANALYSTS PT OF $5 SHARE THIS ⚠️ 📢 🚨 ⚠️
Jan, 20, 2023
$HTGM primed for $10+: STRONG BUY signal 700K flo... See more
Divihomes is Now Live
Check out our new advanced search tool that can help you find the best home services in your area.
Search & Match
Instant Communication
Unbiased Reviews
100% Free
TGTX
TG Therapeutics Inc
-19.05%
$18.43 - $14.92
Feb 7th 2023 - Mar 21st 2023
Dec, 30, 2022
The analyst comments "TGTX stock is up >15... See more
Dec, 30, 2022
Ignorant analyst are a plus.
Jan, 23, 2023
Micro float (~600K), great company with increase in YoY revenue, and high analyst price targets.
Jan, 20, 2023
$HTGM primed for $10+: STRONG BUY signal 700K float 500%+ Cost to Borrow $3M MC w/ $14M in cash Recent analyst targets of $15.00+ Excellent technical setup Also watching: $WISA $SLRX $GNUS
Jan, 20, 2023
GNUS GNUS ⚠️ 📢 🚨 ANALYSTS PT OF $5 SHARE THIS ⚠️ 📢 🚨 ⚠️
Jan, 20, 2023
$HTGM primed for $10+: STRONG BUY signal 700K float 500%+ Cost to Borrow $3M MC w/ $14M in cash Recent analyst targets of $15.00+ Excellent technical setup Also watching: $WISA $SLRX $GNUS
Dec, 30, 2022
The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,
Dec, 30, 2022
Ignorant analyst are a plus.
Dec, 30, 2022
This stock would go far beyond analysts Price Target.
Dec, 30, 2022
$TGTX , absolutely amazing….Scumbag’s Bank of America analyst rated TG today as underperform $6….total joke….I guess the analyst is waiting for FDA approval…LOL ….stick to loans and mortgages….very bullish TG community Longs….
Dec, 29, 2022
The analyst comments "TGTX stock is up >15% (versus +4% for XBI) driven by: 1) positive comments on pricing: we think list price is rational with some discount vs. Ocrevus to lower cost burden and get broad access,